The novel peptide <scp>DR4penA</scp> attenuates the bleomycin‐ and paraquat‐induced pulmonary fibrosis by suppressing the <scp>TGF</scp> ‐ <i>β</i> /Smad signaling pathwayDan Wang, Rui Wang, Xiang Zhang et al.|The FASEB Journal|2023Cited by 7
Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad AxisBochuan Deng, Junqiu Xie, Jiao Zhang et al.|ACS Pharmacology & Translational Science|2024Cited by 3
The Peptide DH α-(4-pentenyl)-ANPQIR-NH2 Exhibits Antifibrotic Activity in Multiple Pulmonary Fibrosis Models Induced by Particulate and Soluble Chemical Fibrogenic AgentsJieru Li, Rui Wang, Bochuan Deng et al.|Journal of Pharmacology and Experimental Therapeutics|2023Cited by 2